Vivos Company Description
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States.
It develops an yttrium-90 based precision radionuclide therapy device, RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; IsoPet for the treatment of solid tumors in animals; a universal laboratory cooling device; hydrogel; and other products under the Alpha-Gel, Beta-Gel, Gamma-Gel, and Precisiongel names.
The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017.
Vivos Inc. was incorporated in 1994 and is headquartered in Kennewick, Washington.
| Country | United States |
| Founded | 1994 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Michael Korenko |
Contact Details
Address: 1030 North Center Parkway Kennewick, Delaware 99352 United States | |
| Phone | 509 222 2222 |
| Website | radiogel.com |
Stock Details
| Ticker Symbol | RDGL |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US92858K2042 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. Michael K. Korenko Ph.D. | Chief Executive Officer, President and Director |
| Dr. Carlton M. Cadwell D.D.S. | Independent Chairman and Secretary |
| Michael H. Pollack CPA | Chief Financial Officer |
| Dr. David J. Swanberg M.S., P.E. | Chief Technical Manager |
| LeeAnna D. Binder | Social Media and Marketing Manager |